ESC 365 - Cardiac dysfunction related to cancer therapy: can we predict who will develop it?

ESC Professional Premium Access

Cardiac dysfunction related to cancer therapy: can we predict who will develop it?

Session: Prediction and management for cardiac dysfunction related to cancer therapy

Topic: Pathophysiology and Mechanisms

Speaker: Doctor H. Akazawa (Tokyo, JP)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Hiroshi Akazawa

The University of Tokyo, Tokyo (Japan)

1 presentation

0 follower

4 more presentations in this session

Welcome from Japanese Circulation Society.

Speaker: Professor Y. Takeishi (Fukushima, JP)

Cardiac dysfunction related to cancer therapy: diagnosis and prognostication.

Speaker: Professor N. Lang (Glasgow, GB)

Cardiac dysfunction related to cancer therapy: personalised management.

Speaker: Doctor K. Tajiri (Kashiwa, JP)

Prediction and management for cardiac dysfunction related to cancer therapy – discussion.

Access the full session

Prediction and management for cardiac dysfunction related to cancer therapy

Speakers: Doctor H. Akazawa, Professor Y. Takeishi, Professor N. Lang, Doctor K. Tajiri

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources